erve Growth Factor β validation study

• Conditions: erve growth factor β Healty volunteers

• Registration Number: NL-OMON25927
• Lead Sponsor: VU University Medical Center, Amsterdam

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 11 June 2024

Recruitment & Eligibility

• Status: Pending
• Sex: Not specified
• Target Recruitment: 60

Inclusion Criteria

Both male and female volunteers.

-18 years or older.

Exclusion Criteria

-Contraindications for donating blood (phlebitis, dermatitis, psoriasis, lymphedema, arterial venous fistula, hematoma on or around insert place, mamma-amputation or axillary dissection of lymph nodes).

- Age younger than 18 years.

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The main study parameters will be the correlation between the DBS and saliva methods compared to venous blood sampling. In order to do so, NGF-β concentrations (pg/ml) for each method will be measured. The difference between saliva testing and venous blood and the difference between dried blood spot and venous blood will be calculated.

Secondary Outcome Measures

Name	Time	Method
In the informed consent volunteers are asked for their permission to use stored samples to measure other reproduction related hormones.